Last price paid | 2.49 | |
Change | +6.41% [ +0.15 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 11.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 03.10.2022 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +552.86% |
Year to date (YTD) | +159.38% |
1 month | +25.13% |
3 months | +39.11% |
1 year | +144.12% |
3 years | n.a. |
Issue price | 0.35 |
Underlying price on issue | 18.66 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1206976032 |
Symbol | IXGABZ |
Security | 120697603 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Troy Ounce of Silver |
Underlying ISIN | XC0009653103 |
Funding level | 20.563000 |
Stop-loss level | 21.103100 |
Distance to stop-loss level | 31.25% |
Long/Short type | Long |
Subscription ratio | 4.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 26.09.2022 |
Premium | 0.23% |
Premium p.a. | n.a. |
Leverage | 3.01 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 10.133000 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
NOVARTIS N | 100.54 |
UBS | 28.01 |
ROCHE GS | 254.40 |
ABB Ltd | 51.22 |
Partners Group Ho... | 1'235.00 |
Name | Price |
---|---|
KUEHNE & NAGEL | 257.00 |
SONOVA HLDG N | 275.30 |
Swiss Life Hldg | 674.80 |
LOGITECH INT. | 81.62 |
Givaudan | 4'352.00 |